Comparison of the sensitivity and specificity of p16/Ki-67 dual staining and HPV DNA testing of abnormal cervical cytology in the detection of histology proven cervical intraepithelial neoplasia grade 2 and above (CIN 2+)
- PMID: 29279588
Comparison of the sensitivity and specificity of p16/Ki-67 dual staining and HPV DNA testing of abnormal cervical cytology in the detection of histology proven cervical intraepithelial neoplasia grade 2 and above (CIN 2+)
Abstract
Introduction: Human papillomavirus (HPV) testing is used as a means of triaging cervico-vaginal smears with low grade squamous abnormalities or as part of co-testing with cytology. While HPV testing has a high sensitivity, it has a low specificity in detecting cervical intraepithelial neoplasia grade 2 and above (CIN 2+) leading to unnecessary colposcopy referrals. We investigate the accuracy of the p16/Ki-67 dual immunocytochemical stain in determining the presence of CIN 2+ lesions on histology and its potential as a superior biomarker for triage.
Methods: Liquid based cervico-vaginal cytology specimens with squamous abnormalities and corresponding histology from 97 women with subsequent colposcopy and biopsy were included. The specimens were then subjected to the dual stain and Roche Cobas 4800 multiplex real time PCR HPV DNA testing. The sensitivity and specificity of the dual stain and HPV testing were calculated using CIN 2+ on histology as a reference standard.
Results: The sensitivity and specificity of the dual stain in detecting histology proven CIN 2+ was 93.7% and 76.5% while HPV testing was 85.7% and 14.7% respectively. Of the 44 women with ASCUS or LSIL on cytology, the dual stain also reduced the number of unnecessary colposcopy referrals from 27 to 7 when used as a triage marker compared to HPV testing.
Conclusion: p16/Ki-67 dual stain was more sensitive and specific than HPV testing in determining the presence of CIN 2+ on histology. It could triage low grade cervico-vaginal specimens more effectively and potentially help women avoid unnecessary colposcopies. Future studies are needed to further evaluate its role in cervical cancer screening programmes.
Similar articles
-
Good performance of p16/Ki-67 dual-stain cytology for detection and post-treatment surveillance of high-grade CIN/VAIN in a prospective, cross-sectional study.Diagn Cytopathol. 2020 Jul;48(7):635-644. doi: 10.1002/dc.24427. Epub 2020 Apr 10. Diagn Cytopathol. 2020. PMID: 32275355
-
Clinical value of fully automated p16/Ki-67 dual staining in the triage of HPV-positive women in the Norwegian Cervical Cancer Screening Program.Cancer Cytopathol. 2017 Apr;125(4):283-291. doi: 10.1002/cncy.21807. Epub 2016 Dec 5. Cancer Cytopathol. 2017. PMID: 27918650
-
[Clinical value of p16INK4a immunocytochemistry in cervical cancer screening].Zhonghua Fu Chan Ke Za Zhi. 2020 Nov 25;55(11):784-790. doi: 10.3760/cma.j.cn112141-20200520-00428. Zhonghua Fu Chan Ke Za Zhi. 2020. PMID: 33228350 Chinese.
-
Cytology versus HPV testing for cervical cancer screening in the general population.Cochrane Database Syst Rev. 2017 Aug 10;8(8):CD008587. doi: 10.1002/14651858.CD008587.pub2. Cochrane Database Syst Rev. 2017. PMID: 28796882 Free PMC article. Review.
-
Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions.Cochrane Database Syst Rev. 2013 Mar 28;2013(3):CD008054. doi: 10.1002/14651858.CD008054.pub2. Cochrane Database Syst Rev. 2013. PMID: 23543559 Free PMC article. Review.
Cited by
-
Risk Factors for Persistence or Recurrence of High-Grade Cervical Squamous Intraepithelial Lesions.Rev Col Bras Cir. 2023 Dec 1;50:e20233537. doi: 10.1590/0100-6991e-20233537-en. eCollection 2023. Rev Col Bras Cir. 2023. PMID: 38055549 Free PMC article.
-
Association between Cervical Microbiota and HPV: Could This Be the Key to Complete Cervical Cancer Eradication?Biology (Basel). 2022 Jul 26;11(8):1114. doi: 10.3390/biology11081114. Biology (Basel). 2022. PMID: 35892970 Free PMC article. Review.
-
Significance of Triple Detection of p16/ki-67 Dual-Staining, Liquid-Based Cytology and HR HPV Testing in Screening of Cervical Cancer: A Retrospective Study.Front Oncol. 2022 Jun 7;12:915418. doi: 10.3389/fonc.2022.915418. eCollection 2022. Front Oncol. 2022. PMID: 35747800 Free PMC article.
-
The p16/ki-67 assay is a safe, effective and rapid approach to triage women with mild cervical lesions.PLoS One. 2021 Jun 11;16(6):e0253045. doi: 10.1371/journal.pone.0253045. eCollection 2021. PLoS One. 2021. PMID: 34115809 Free PMC article.
-
SOX14 hypermethylation as a tumour biomarker in cervical cancer.BMC Cancer. 2021 Jun 7;21(1):675. doi: 10.1186/s12885-021-08406-2. BMC Cancer. 2021. PMID: 34098886 Free PMC article.